NFYA regulates two sequential genome-wide transcriptional activation events during oocyte-to-embryo transition

1. Problem Statement

The transition from oocyte to embryo involves two critical, sequential waves of genome-wide transcriptional activation:

1. Primordial Follicle Oocyte Activation (PFA): The awakening of dormant primordial follicles to initiate oocyte growth and folliculogenesis.
2. Zygotic Genome Activation (ZGA): The activation of the embryonic genome following fertilization, enabling the maternal-to-zygotic transition (MZT).

While both processes share molecular hallmarks (ribosome biogenesis, massive protein synthesis, chromatin remodeling), the specific pioneer transcription factors (TFs) that initiate these events have remained elusive. Previous studies identified repressors of quiescence (e.g., PTEN, FOXO3A) but lacked a unified activator for both PFA and ZGA. The study aims to identify a single regulator capable of orchestrating transcriptional activation in both distinct developmental contexts.

2. Methodology

The authors employed a multi-faceted approach combining genetic models, acute protein degradation, and multi-omics profiling:

• Genetic Models:
  • Oocyte-specific Knockout (cKO): Generated Gdf9-Cre Nfya^flox/flox mice to deplete NFYA specifically in oocytes starting from the primordial follicle stage.
  • Acute Degradation (dTAG): Generated Nfya^dTAG mice (HA-FKBP-NFYA fusion) to allow rapid, conditional degradation of NFYA in zygotes/embryos using the small molecule dTAG13, bypassing the lethality of constitutive knockout.
• Omics Profiling:
  • RNA-seq: Performed on primordial, primary, and secondary follicle oocytes (WT vs. cKO) and late 2-cell (L2C) embryos (WT vs. dTAG13-treated).
  • ATAC-seq: Assessed chromatin accessibility changes in oocytes and embryos upon NFYA loss.
  • CUT&RUN: Low-input CUT&RUN assays were used to map NFYA binding sites in primary/secondary follicle oocytes and L2C embryos.
• Phenotypic & Mechanistic Assays:
  • Histology: H&E staining of ovaries to assess folliculogenesis.
  • Cell Death Analysis: Ferroptosis markers (FerroOrange for Fe²⁺, BODIPY C11 for lipid peroxidation), apoptosis/autophagy markers (cleaved caspase-3, LC3), and electron microscopy (mitochondria/ER structure).
  • Rescue Experiments: In vitro 3D follicle culture with the ferroptosis inhibitor Ferrostatin-1 (Fer-1).
  • Chaperone Inhibition: Treatment of embryos and ovaries with HSP90 inhibitor (Ganetespib) and HSPA2/5 inhibitor (VER155008) to test the functional requirement of NFYA-regulated chaperones.
  • Bioinformatics: Motif enrichment, Gene Ontology (GO) analysis, and Activity-by-Contact (ABC) modeling for promoter-enhancer interactions.

3. Key Contributions

• Identification of NFYA as a Unified Regulator: The study establishes NFYA as the first identified pioneer factor that drives transcriptional activation in both PFA and ZGA.
• Distinct Chromatin Binding Landscapes: It reveals that NFYA exhibits stage-specific binding preferences: predominantly promoter-targeting during PFA and enhancer/distal-targeting during ZGA.
• Conserved Pre-occupancy Mechanism: The authors discovered a set of "common" NFYA-bound regions (mostly promoters) that are pre-occupied in both primordial oocytes and zygotes before activation begins. These regions regulate essential housekeeping genes (chaperones and histones) required for both transitions.
• Novel Cell Death Mechanism: The study links NFYA deficiency in oocytes to a specific form of non-canonical ferroptosis, characterized by altered cytoplasmic iron distribution and ER stress rather than canonical iron overload.

4. Key Results

A. NFYA is Essential for PFA and Folliculogenesis

• Phenotype: Nfya-cKO mice are infertile. Ovaries show a drastic loss of primary and secondary follicles, leading to early folliculogenesis failure and degeneration.
• Transcriptional Impact: Loss of NFYA prevents the activation of "early-PFA" and "late-PFA" genes. RNA-seq showed 809 downregulated genes in primary follicles and 1,844 in secondary follicles.
• Mechanism: CUT&RUN confirmed NFYA binds directly to promoters of downregulated genes (e.g., Prkaca, Hspa2, Kdm4a). ATAC-seq revealed that NFYA loss significantly reduces chromatin accessibility at these promoters, confirming its role as a pioneer factor.
• Cell Death: NFYA deficiency triggers non-canonical ferroptosis.
  • Evidence: Downregulation of ferroptosis suppressors (Pdia4, Hspa5, Nfe2l1); abnormal cytoplasmic Fe²⁺ distribution (FerroOrange); excessive lipid peroxidation (BODIPY C11); and ultrastructural damage to mitochondria and ER (EM).
  • Rescue: Treatment with Ferrostatin-1 (Fer-1) significantly reduced oocyte degeneration, confirming ferroptosis as the cause of failure.

B. NFYA is Critical for ZGA and Preimplantation Development

• Phenotype: Acute degradation of NFYA in Nfya^dTAG embryos using dTAG13 caused ~50% of embryos to arrest at the 2-cell stage and ~90% failure to reach the blastocyst stage.
• Transcriptional Impact: NFYA depletion led to the downregulation of 1,067 major ZGA genes.
• Binding Specificity: Unlike in oocytes, NFYA in L2C embryos binds predominantly to distal regions (enhancers) (85.5% of L2C-specific peaks) in addition to promoters.
• Independence: NFYA regulates ZGA independently of other known ZGA factors like OBOX and DUX, though there is overlap in target genes. NFYA binds promoters of shared targets, while OBOX binds gene bodies.

C. The "Pre-occupied" Common Mechanism

• Common Targets: 920 NFYA binding regions are conserved between oocytes and L2C embryos. These regions are pre-occupied (bound and accessible) in both dormant primordial oocytes and zygotes before the onset of PFA or ZGA.
• Target Genes: These common regions regulate genes involved in protein folding, ER stress response, and nucleosome organization, specifically chaperones (e.g., Hspa2, Hspa5, Hsp90b1) and histone genes.
• Functional Validation: Inhibiting chaperones (using Ganetespib + VER155008) in both in vitro cultured ovaries (PFA) and embryos (ZGA) recapitulated the defects seen in Nfya loss, causing oocyte arrest and 2-cell embryo arrest. This confirms that NFYA's regulation of chaperones is a conserved, essential mechanism for genome activation.

5. Significance

• Unified Model of Genome Reactivation: The study provides a unified mechanistic framework for how the genome is reactivated after long periods of quiescence (dormant oocytes) and after cell division (zygotes). It demonstrates that a single TF (NFYA) can orchestrate these events through a combination of stage-specific binding (promoters vs. enhancers) and conserved pre-occupancy of essential machinery (chaperones/histones).
• Insight into Female Infertility: The findings elucidate a molecular cause for early folliculogenesis failure and oocyte degeneration, linking transcriptional regulation directly to ferroptosis, a previously underappreciated mechanism in ovarian aging and failure.
• Therapeutic Implications: The identification of chaperones as critical downstream effectors of NFYA suggests that modulating protein folding capacity could be a potential strategy to rescue defects in oocyte maturation or early embryonic development.
• Broader Biological Context: The authors propose that NFYA may serve as a general "reactivation" factor for transcription in other contexts involving quiescence-to-activation transitions, such as stem cell activation or tissue regeneration.

In summary, this paper defines NFYA as a multifaceted pioneer factor that ensures the successful oocyte-to-embryo transition by dynamically remodeling chromatin and maintaining proteostasis through chaperone regulation.